Clinical Trials in Austin

Showing 4981-5000 of 15,205 trials

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Neoplasms

Vincerx Pharma, Inc.110 participantsStarted Feb 2016

Springdale, Arkansas, United States • Louisville, Kentucky, United States • Silver Spring, Maryland, United States +13 more locations

COMPLETEDPhase 262 miles

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

NCT02639182

The purpose of this study was to evaluate the progression free survival (PFS), based on investigator radiologic review, of AGS-16C3F compared to axitinib in subjects with metastatic renal cell carcinoma.

Metastatic Renal Cell Carcinoma

Astellas Pharma Global Development, Inc.133 participantsStarted May 2016

Tucson, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +23 more locations

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Find Trials by Condition in Austin

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Extravascular ICD Pivotal Study

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions